zoledronic acid has been researched along with Giant Cell Tumor of Bone in 18 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (16.67) | 29.6817 |
2010's | 12 (66.67) | 24.3611 |
2020's | 3 (16.67) | 2.80 |
Authors | Studies |
---|---|
Bovée, JVMG; Gelderblom, H; Lipplaa, A; van de Sande, MAJ; van der Heijden, L; van Langevelde, K | 1 |
Dijkstra, S; Gelderblom, H; van de Sande, M; van der Heijden, L | 1 |
Li, J; Liu, Y; Song, W; Sun, X; Zhou, J | 1 |
Dezawa, A; Kamijo, R; Karakawa, A; Miyamoto, A; Nakamura, S; Shibuya, I; Takami, M | 1 |
Li, M; Lu, Y; Mao, C; Wan, P; Wang, W; Yang, K; Zhang, Y; Zhu, Y | 1 |
Couch, C; Emory, CL; Montgomery, C; Nicholas, R | 1 |
Huang, L; Kumta, SM; Lau, CP; Wong, KC | 1 |
Li, M; Lin, X; Yang, T; Yin, QS; Zheng, XF | 1 |
Anract, P; Bonnevialle, P; Di Marco, A; Fiorenza, F; Gouin, F; Rochwerger, AR; Rosset, P | 1 |
Hanaoka, N; Kenji, E; Miyagi, R; Nishisho, T; Sairyo, K; Sakai, T; Takahashi, M; Toki, S; Yasui, N | 1 |
Chen, CF; Chen, KH; Chen, WM; Wu, PK | 1 |
Huang, L; Kumta, SM; Lau, CP; Li, G; Tsui, SK; Wong, KC | 1 |
Arpornchayanon, O; Leerapun, T | 1 |
Athanasou, N; Balke, M; Campanacci, L; Gebert, C; Gibbons, M; Hogendoorn, P; Kroep, J; Picci, P; Taylor, R; Wass, J | 1 |
Endo, K; Hanaoka, N; Nishisho, T; Takahashi, M; Yasui, N | 1 |
Gille, O; Guerin, P; Lepreux, S; Oliveira, Bde A; Richez, C; Vital, JM | 1 |
Cheng, YY; Huang, L; Kumta, SM; Lee, KM; Xu, JK; Zheng, MH | 1 |
Blaine, TA; Chang, SS; Doppelt, JD; Jung, KM; Kim, TW; Lee, FY; Suratwala, SJ; Winchester, RJ; Zhang, HZ | 1 |
5 review(s) available for zoledronic acid and Giant Cell Tumor of Bone
Article | Year |
---|---|
Updated concepts in treatment of giant cell tumor of bone.
Topics: B7-H1 Antigen; Bone Cements; Bone Density Conservation Agents; Bone Neoplasms; Denosumab; Giant Cell Tumor of Bone; Humans; Randomized Controlled Trials as Topic; Zoledronic Acid | 2022 |
Current concepts in the treatment of giant cell tumour of bone.
Topics: Bone Density Conservation Agents; Bone Neoplasms; Denosumab; Giant Cell Tumor of Bone; Humans; Neoadjuvant Therapy; Randomized Controlled Trials as Topic; Zoledronic Acid | 2020 |
Comprehensive treatment for multicentric giant cell tumors of the pelvis and spine using apatinib: A case report and literature review.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Female; Giant Cell Tumor of Bone; Humans; Pelvic Neoplasms; Pyridines; Spinal Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Zoledronic Acid | 2020 |
Giant Cell Tumor of Bone: Review of Current Literature, Evaluation, and Treatment Options.
Topics: Bone Cements; Bone Density Conservation Agents; Bone Neoplasms; Bone Transplantation; Curettage; Denosumab; Giant Cell Tumor of Bone; Humans; Tibia; Zoledronic Acid | 2019 |
Effectiveness of intravenous bisphosphonate in treatment of giant cell tumor: a case report and review of the literature.
Topics: Adult; Bone Density Conservation Agents; Diphosphonates; Female; Giant Cell Tumor of Bone; Humans; Imidazoles; Infusion Pumps; Sacrum; Zoledronic Acid | 2008 |
1 trial(s) available for zoledronic acid and Giant Cell Tumor of Bone
Article | Year |
---|---|
Adjuvant treatment with zoledronic acid after extensive curettage for giant cell tumours of bone.
Topics: Adult; Aged; Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Female; Giant Cell Tumor of Bone; Humans; Imidazoles; Male; Middle Aged; Neoplasm Recurrence, Local; Young Adult; Zoledronic Acid | 2014 |
12 other study(ies) available for zoledronic acid and Giant Cell Tumor of Bone
Article | Year |
---|---|
In Vitro Study of the Effects of Denosumab on Giant Cell Tumor of Bone: Comparison with Zoledronic Acid.
Topics: Adult; Apoptosis; Bone Density Conservation Agents; Bone Neoplasms; Bone Resorption; Cell Proliferation; Denosumab; Giant Cell Tumor of Bone; Humans; In Vitro Techniques; Male; Middle Aged; Osteoclasts; Prognosis; Tumor Cells, Cultured; Zoledronic Acid | 2019 |
Molecular and cellular mechanisms for zoledronic acid-loaded magnesium-strontium alloys to inhibit giant cell tumors of bone.
Topics: Alloys; Apoptosis; Biocompatible Materials; Bone and Bones; Bone Neoplasms; Calcium Phosphates; Cell Movement; Cytoskeleton; Diphosphonates; Giant Cell Tumor of Bone; Humans; Magnesium; Mitochondria; Neoplasm Metastasis; Neoplasms; NF-kappa B; Osteoclasts; Osteolysis; Oxidative Stress; Recurrence; Risk Factors; Signal Transduction; Strontium; Zoledronic Acid | 2018 |
Comparison of the anti-tumor effects of denosumab and zoledronic acid on the neoplastic stromal cells of giant cell tumor of bone.
Topics: Alkaline Phosphatase; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Apoptosis; Cell Count; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Collagen Type I; Denosumab; Diphosphonates; Gene Expression Regulation, Neoplastic; Giant Cell Tumor of Bone; Humans; Imidazoles; Macrophage Colony-Stimulating Factor; Osteoprotegerin; RANK Ligand; RNA, Messenger; Solubility; Stromal Cells; Zoledronic Acid | 2013 |
Stimulation of osteogenic differentiation in stromal cells of giant cell tumour of bone by zoledronic acid.
Topics: Biomarkers, Tumor; Bone Density Conservation Agents; Bone Neoplasms; Cell Differentiation; Core Binding Factor Alpha 1 Subunit; Diphosphonates; Giant Cell Tumor of Bone; Humans; Imidazoles; Immunoenzyme Techniques; Osteocalcin; Osteogenesis; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sp7 Transcription Factor; Stromal Cells; Transcription Factors; Tumor Cells, Cultured; Zoledronic Acid | 2013 |
Local administration of zoledronic acid for giant cell tumor of bone.
Topics: Administration, Topical; Adult; Aged; Bone Density Conservation Agents; Bone Neoplasms; Bone Substitutes; Combined Modality Therapy; Diphosphonates; Female; Giant Cell Tumor of Bone; Humans; Imidazoles; Male; Middle Aged; Neoplasm Recurrence, Local; Young Adult; Zoledronic Acid | 2015 |
Zoledronic acid-loaded bone cement as a local adjuvant therapy for giant cell tumor of the sacrum after intralesional curettage.
Topics: Adolescent; Adult; Bone Cements; Bone Density Conservation Agents; Bone Neoplasms; Cohort Studies; Combined Modality Therapy; Curettage; Diphosphonates; Female; Giant Cell Tumor of Bone; Humans; Imidazoles; Male; Polyradiculopathy; Retrospective Studies; Sacrum; Young Adult; Zoledronic Acid | 2015 |
A mouse model of luciferase-transfected stromal cells of giant cell tumor of bone.
Topics: Animals; Benzamides; Bone Neoplasms; Cell Line, Tumor; Diphosphonates; Female; Giant Cell Tumor of Bone; Heterografts; Humans; Imidazoles; Luciferases; Male; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Stromal Cells; Transduction, Genetic; Xenograft Model Antitumor Assays; Zoledronic Acid | 2015 |
Bisphosphonate treatment of aggressive primary, recurrent and metastatic Giant Cell Tumour of Bone.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bone Neoplasms; Bone Resorption; Diphosphonates; Female; Giant Cell Tumor of Bone; Humans; Imidazoles; Lung Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Osteoclasts; Treatment Outcome; Tumor Cells, Cultured; Young Adult; Zoledronic Acid | 2010 |
Locally administered zoledronic Acid therapy for giant cell tumor of bone.
Topics: Adult; Antineoplastic Agents; Bone Density Conservation Agents; Bone Neoplasms; Bone Substitutes; Bone Transplantation; Curettage; Diphosphonates; Giant Cell Tumor of Bone; Humans; Hydroxyapatites; Imidazoles; Knee Joint; Male; Necrosis; Osteoclasts; Osteolysis; Prostheses and Implants; Radiography; Range of Motion, Articular; Remission Induction; Tibia; Zoledronic Acid | 2011 |
Regression of giant cell tumor of the cervical spine with bisphosphonate as single therapy.
Topics: Bone Density Conservation Agents; Cervical Vertebrae; Diphosphonates; Giant Cell Tumor of Bone; Humans; Imidazoles; Male; Middle Aged; Spinal Neoplasms; Treatment Outcome; Zoledronic Acid | 2012 |
Bisphosphonates induce apoptosis of stromal tumor cells in giant cell tumor of bone.
Topics: Alendronate; Antineoplastic Agents; Apoptosis; Bone Neoplasms; Diphosphonates; DNA Fragmentation; DNA, Neoplasm; Dose-Response Relationship, Drug; Flow Cytometry; Giant Cell Tumor of Bone; Humans; Imidazoles; In Situ Nick-End Labeling; Osteoclasts; Pamidronate; Stromal Cells; Tumor Cells, Cultured; Zoledronic Acid | 2004 |
Bisphosphonates may reduce recurrence in giant cell tumor by inducing apoptosis.
Topics: Annexin A5; Apoptosis; Bone Neoplasms; Caspase 3; Caspases; Diphosphonates; Dose-Response Relationship, Drug; Flow Cytometry; Giant Cell Tumor of Bone; Humans; Imidazoles; Immunohistochemistry; Pamidronate; Poly Adenosine Diphosphate Ribose; Tumor Cells, Cultured; Zoledronic Acid | 2004 |